# F&G Annuities & Life, Inc.: financial statements, quarterly

FG · NYSE · CIK 1934850 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fg.md) · [Financials](/companies/fg/financials.md) · [Filings](/companies/fg/filings.md) · [Insiders](/companies/fg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [851](/filings/0001934850-24-000055.md) | [1,612 d](/filings/0001934850-26-000026.md) | [1,569](/filings/0001934850-25-000024.md) | [1,172](/filings/0001934850-25-000043.md) | [1,444](/filings/0001934850-25-000072.md) | [1,559 d](/filings/0001934850-26-000026.md) | [908](/filings/0001934850-26-000057.md) | [1,364](/filings/0001934850-26-000085.md) | [1,694](/filings/0001934850-25-000072.md) | [1,765 d](/filings/0001934850-26-000026.md) | [1,187](/filings/0001934850-26-000057.md) | [1,421](/filings/0001934850-26-000085.md) |
| Interest expense | $m | [24.0](/filings/0001934850-24-000055.md) | [26.0 d](/filings/0001934850-25-000015.md) | [30.0](/filings/0001934850-25-000024.md) | [28.0](/filings/0001934850-25-000043.md) | [36.0](/filings/0001934850-24-000055.md) | [38.0 d](/filings/0001934850-25-000015.md) | [40.0](/filings/0001934850-25-000024.md) | [41.0](/filings/0001934850-25-000043.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [74.0](/filings/0001934850-24-000055.md) | [(76.0) d](/filings/0001934850-26-000026.md) | [26.0](/filings/0001934850-25-000024.md) | [50.0](/filings/0001934850-25-000043.md) | [(25.0)](/filings/0001934850-25-000072.md) | [85.0 d](/filings/0001934850-26-000026.md) | [(5.0)](/filings/0001934850-26-000057.md) | [15.0](/filings/0001934850-26-000085.md) | [11.0](/filings/0001934850-25-000072.md) | [31.0 d](/filings/0001934850-26-000026.md) | [74.0](/filings/0001934850-26-000057.md) | [(19.0)](/filings/0001934850-26-000085.md) |
| Net income | $m | [306](/filings/0001934850-24-000055.md) | [(299) d](/filings/0001934850-26-000026.md) | [115](/filings/0001934850-25-000024.md) | [203](/filings/0001934850-25-000043.md) | [(6.0)](/filings/0001934850-25-000072.md) | [327 d](/filings/0001934850-26-000026.md) | [(21.0)](/filings/0001934850-26-000057.md) | [40.0](/filings/0001934850-26-000085.md) | [118](/filings/0001934850-25-000072.md) | [128 d](/filings/0001934850-26-000026.md) | [248](/filings/0001934850-26-000057.md) | [(76.0)](/filings/0001934850-26-000085.md) |
| Diluted EPS | $ per share | [2.45](/filings/0001934850-24-000055.md) | not reported | [0.88](/filings/0001934850-25-000024.md) | [1.55](/filings/0001934850-25-000043.md) | [(0.08)](/filings/0001934850-25-000072.md) | not reported | [(0.20)](/filings/0001934850-26-000057.md) | [0.26](/filings/0001934850-26-000085.md) | [0.85](/filings/0001934850-25-000072.md) | not reported | [1.78](/filings/0001934850-26-000057.md) | [(0.62)](/filings/0001934850-26-000085.md) |
| Basic EPS | $ per share | [2.47](/filings/0001934850-24-000055.md) | not reported | [0.90](/filings/0001934850-25-000024.md) | [1.60](/filings/0001934850-25-000043.md) | [(0.08)](/filings/0001934850-25-000072.md) | not reported | [(0.20)](/filings/0001934850-26-000057.md) | [0.26](/filings/0001934850-26-000085.md) | [0.86](/filings/0001934850-25-000072.md) | not reported | [1.83](/filings/0001934850-26-000057.md) | [(0.62)](/filings/0001934850-26-000085.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.7](/filings/0001934850-23-000068.md) | [1.6](/filings/0001934850-25-000015.md) | [2.4](/filings/0001934850-24-000027.md) | [3.5](/filings/0001934850-24-000045.md) | [3.5](/filings/0001934850-24-000055.md) | [2.3](/filings/0001934850-26-000026.md) | [3.3](/filings/0001934850-25-000024.md) | [1.9](/filings/0001934850-25-000043.md) | [2.2](/filings/0001934850-25-000072.md) | [1.5](/filings/0001934850-26-000085.md) | [1.3](/filings/0001934850-26-000057.md) | [2.1](/filings/0001934850-26-000085.md) |
| Total assets | $bn | [63.6](/filings/0001934850-23-000068.md) | [70.2](/filings/0001934850-25-000015.md) | [74.4](/filings/0001934850-24-000027.md) | [78.5](/filings/0001934850-24-000045.md) | [84.1](/filings/0001934850-24-000055.md) | [84.9](/filings/0001934850-26-000026.md) | [88.0](/filings/0001934850-25-000024.md) | [91.8](/filings/0001934850-25-000043.md) | [96.1](/filings/0001934850-25-000072.md) | [98.4](/filings/0001934850-26-000085.md) | [101](/filings/0001934850-26-000057.md) | [104](/filings/0001934850-26-000085.md) |
| Total liabilities | $bn | [61.3](/filings/0001934850-23-000068.md) | [67.1](/filings/0001934850-25-000015.md) | [70.8](/filings/0001934850-24-000027.md) | [74.7](/filings/0001934850-24-000045.md) | [79.6](/filings/0001934850-24-000055.md) | [80.9](/filings/0001934850-26-000026.md) | [83.5](/filings/0001934850-25-000024.md) | [87.3](/filings/0001934850-25-000043.md) | [91.2](/filings/0001934850-25-000072.md) | [93.5](/filings/0001934850-26-000085.md) | [96.3](/filings/0001934850-26-000057.md) | [98.9](/filings/0001934850-26-000085.md) |
| Long-term debt | $bn | [1.6](/filings/0001934850-23-000068.md) | [1.8](/filings/0001934850-25-000015.md) | [1.7](/filings/0001934850-24-000027.md) | [2.0](/filings/0001934850-24-000045.md) | [2.0](/filings/0001934850-24-000055.md) | [2.2](/filings/0001934850-26-000026.md) | [2.2](/filings/0001934850-25-000024.md) | [2.2](/filings/0001934850-25-000043.md) | [2.2](/filings/0001934850-25-000072.md) | [2.2](/filings/0001934850-26-000085.md) | [2.2](/filings/0001934850-26-000057.md) | [2.2](/filings/0001934850-26-000085.md) |
| Shareholders' equity | $bn | [2.4](/filings/0001934850-23-000068.md) | [3.1](/filings/0001934850-25-000015.md) | [3.5](/filings/0001934850-24-000027.md) | [3.7](/filings/0001934850-24-000045.md) | [4.3](/filings/0001934850-24-000055.md) | [4.0](/filings/0001934850-26-000026.md) | [4.4](/filings/0001934850-25-000024.md) | [4.4](/filings/0001934850-25-000043.md) | [4.8](/filings/0001934850-25-000072.md) | [4.8](/filings/0001934850-26-000085.md) | [4.6](/filings/0001934850-26-000057.md) | [4.6](/filings/0001934850-26-000085.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [795 d](/filings/0001934850-24-000055.md) | [2,222 d](/filings/0001934850-26-000026.md) | [1,534](/filings/0001934850-25-000024.md) | [1,055 d](/filings/0001934850-25-000043.md) | [2,090 d](/filings/0001934850-25-000072.md) | [1,320 d](/filings/0001934850-26-000026.md) | [956](/filings/0001934850-26-000057.md) | [1,620 d](/filings/0001934850-26-000085.md) | [937 d](/filings/0001934850-25-000072.md) | [1,168 d](/filings/0001934850-26-000026.md) | [743](/filings/0001934850-26-000057.md) | [1,487 d](/filings/0001934850-26-000085.md) |
| Dividends paid | $m | [25.0 d](/filings/0001934850-23-000068.md) | [26.0 d](/filings/0001934850-24-000018.md) | [26.0](/filings/0001934850-24-000027.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [2.0 d](/filings/0001934850-24-000055.md) | [0.0 d](/filings/0001934850-26-000026.md) | [6.0](/filings/0001934850-25-000024.md) | [0.0 d](/filings/0001934850-25-000043.md) | [0.0 d](/filings/0001934850-25-000072.md) | [6.0 d](/filings/0001934850-26-000026.md) | [3.0](/filings/0001934850-26-000057.md) | [0.0 d](/filings/0001934850-26-000085.md) | [0.0 d](/filings/0001934850-25-000072.md) | [7.0 d](/filings/0001934850-26-000026.md) | [29.0](/filings/0001934850-26-000057.md) | [94.0 d](/filings/0001934850-26-000085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [125](/filings/0001934850-23-000068.md) | [125](/filings/0001934850-24-000027.md) | [125](/filings/0001934850-24-000045.md) | [125](/filings/0001934850-24-000055.md) | [130](/filings/0001934850-25-000024.md) | [131](/filings/0001934850-25-000043.md) | [124](/filings/0001934850-25-000072.md) | [126](/filings/0001934850-26-000057.md) | [134](/filings/0001934850-26-000085.md) | [139](/filings/0001934850-25-000072.md) | [139](/filings/0001934850-26-000057.md) | [130](/filings/0001934850-26-000085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 130,935,209 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001934850-26-000085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.